Why is One Medical valued more richly than Casper?

TL;DR

Casper and One Medical, two recently listed companies, have different valuations despite similar financial characteristics and business models.

Transcript

let's talk about yappy ODEs cuz I feel like after a quiet December if you will and in kind of a medium January we've had two debuts now we've had Casper a mattress company and we've also had one medical what the hell do we call a medical kind of a concierge on-demand medical service business something like that health care 1.5 health care of 1.5 it... Read More

Key Insights

• ✋ Casper and One Medical experienced different IPO valuations, with One Medical being valued significantly higher.
• 👾 Investors' belief in the overall space and business model is crucial for IPO valuations.
• ❓ Increased market understanding of DTC economics can benefit Casper's valuation and performance.
• 😮 Concerns about rising marketing costs in the DTC industry may impact investor perception.
• 🤨 Saturation of marketing channels and rising traffic acquisition costs raise concerns for shareholders.
• ✋ One Medical's conservative pricing and explosive growth may have contributed to its higher valuation.
• 👾 The DTC space is still relatively new in terms of IPOs, requiring additional effort to convince and convert investors.

Questions & Answers

Q: Why is One Medical valued higher than Casper, even though both companies have similar financial characteristics and lack recurring revenue?

Investors in the public market have different theses and apply various multiples to different businesses based on margin profiles and sectors. Finding investors who believe in the overall space and business model is crucial. Additionally, One Medical's conservative pricing and explosive growth may have influenced its higher valuation.

Q: Is this the first direct-to-consumer (DTC) IPO in the market?

While there have been DTC acquisitions, One Medical is one of the first companies in the space to reach the public markets. The new revenue models around marketing and direct-to-consumer operations require investors to understand and support the business model, which may require additional effort to convince and convert investors.

Q: Will the road shows and promotion of the DTC model by other companies in upcoming DTC IPOs help or hurt Casper's long-term prospects?

The increased market understanding of DTC economics and operations can benefit Casper's valuation and performance. It will provide better insight into the company's operations and market space. However, there may also be concerns about rising marketing costs in the DTC industry, which could impact shareholder confidence.

Q: How do concerns about marketing costs impact investor perception of DTC companies?

Shareholders are often worried about increasing marketing costs, especially in highly competitive markets. Saturation of marketing channels and rising traffic acquisition costs can influence investor sentiment and stock performance. However, in the long term, investors may reach an equilibrium and adjust their expectations accordingly.

Summary & Key Takeaways

• Casper and One Medical recently went public, with Casper's IPO price range lowered from $17-19 to $12-13 per share, while One Medical exploded out of the gate and is now worth $25 per share.

• One Medical is valued significantly higher than Casper in terms of revenue multiples, despite both companies being unprofitable and lacking recurring revenue or high gross margins.

• The public market's valuation of these two companies, both operating in the healthcare space, raises questions about how investors perceive and value different businesses.